Nan Fung Group Holdings LTD Biocryst Pharmaceuticals Inc Transaction History

Nan Fung Group Holdings LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$4.89 - $7.65 $92,910 - $145,350	19,000 Added 106.46%	36,847 $187,000
Q1 2023 May 12, 2023	BUY	$7.94 - $11.84 $141,705 - $211,308	17,847 New	17,847 $148,000
Q1 2022 May 13, 2022	SELL	$11.56 - $19.76 $179,700 - $307,169	-15,545 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$11.18 - $15.46 $173,793 - $240,325	15,545 New	15,545 $215,000

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Nan Fung Group Holdings LTD, based on Form 13F filings with the SEC.

Stay updated on Nan Fung Group Holdings LTD with notifications on news.